274 related articles for article (PubMed ID: 29056916)
1. Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy.
Zhang L; An XF; Ruan X; Huang DD; Zhou L; Xue H; Lu LM; He M
Front Physiol; 2017; 8():758. PubMed ID: 29056916
[No Abstract] [Full Text] [Related]
2. Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
Huang J; Matavelli LC; Siragy HM
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):215-21. PubMed ID: 21265872
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II regulates brain (pro)renin receptor expression through activation of cAMP response element-binding protein.
Li W; Liu J; Hammond SL; Tjalkens RB; Saifudeen Z; Feng Y
Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(2):R138-47. PubMed ID: 25994957
[TBL] [Abstract][Full Text] [Related]
5. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
6. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.
Kim CS; Kim IJ; Bae EH; Ma SK; Lee J; Kim SW
PLoS One; 2015; 10(11):e0142664. PubMed ID: 26556707
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
Zhang Z; Zhang Y; Ning G; Deb DK; Kong J; Li YC
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15896-901. PubMed ID: 18838678
[TBL] [Abstract][Full Text] [Related]
9. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Central (Pro)renin Receptor Ameliorates Salt-Induced Renal Injury in Chronic Kidney Disease.
Li J; Liang M; Zeng T; Qiu M; Zhang M; Jiang S; Tan L; Li A
Antioxid Redox Signal; 2021 Jul; 35(2):93-112. PubMed ID: 32757619
[No Abstract] [Full Text] [Related]
11. Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.
Callera GE; Antunes TT; Correa JW; Moorman D; Gutsol A; He Y; Cat AN; Briones AM; Montezano AC; Burns KD; Touyz RM
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27612496
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
13. Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression.
Huang J; Siragy HM
Endocrinology; 2009 Dec; 150(12):5557-65. PubMed ID: 19861503
[TBL] [Abstract][Full Text] [Related]
14. trans-Anethole attenuated renal injury and reduced expressions of angiotensin II receptor (AT1R) and TGF-β in streptozotocin-induced diabetic rats.
Samadi-Noshahr Z; Ebrahimzadeh-Bideskan A; Hadjzadeh MA; Shafei MN; Salmani H; Hosseinian S; Khajavi-Rad A
Biochimie; 2021 Jun; 185():117-127. PubMed ID: 33771655
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II-independent upregulation of cyclooxygenase-2 by activation of the (Pro)renin receptor in rat renal inner medullary cells.
Gonzalez AA; Luffman C; Bourgeois CR; Vio CP; Prieto MC
Hypertension; 2013 Feb; 61(2):443-9. PubMed ID: 23184385
[TBL] [Abstract][Full Text] [Related]
16. SND p102 promotes extracellular matrix accumulation and cell proliferation in rat glomerular mesangial cells via the AT1R/ERK/Smad3 pathway.
Xu JL; Gan XX; Ni J; Shao DC; Shen Y; Miao NJ; Xu D; Zhou L; Zhang W; Lu LM
Acta Pharmacol Sin; 2018 Sep; 39(9):1513-1521. PubMed ID: 30150789
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression.
He M; Zhang L; Shao Y; Xue H; Zhou L; Wang XF; Yu C; Yao T; Lu LM
Mol Cell Endocrinol; 2010 Feb; 315(1-2):188-94. PubMed ID: 19879325
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.
Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
20. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
